Rational testing: Investigating hirsutism

BMJ (Online)

Volumn 338, Issue 7702, 2009, Pages 1070-1071

  Sathyapalan, T ^a   Atkin, Stephen L ^b  

^a HULL ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CYCLOSPORIN A; HYDROCORTISONE; HYDROXYPROGESTERONE; PHENYTOIN; PROLACTIN; TESTOSTERONE; SEX HORMONE;

ACNE; ADULT; ALOPECIA; AMENORRHEA; ANDROGEN SYNTHESIS; BIOCHEMISTRY; BODY MASS; BODY WEIGHT; CASE REPORT; CHIN; CONGENITAL ADRENAL HYPERPLASIA; CUSHING DISEASE; ECHOGRAPHY; FACE; FEMALE; GENERAL PRACTITIONER; HAIR; HAIR GROWTH; HIRSUTISM; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERANDROGENISM; HYPERTRICHOSIS; IMMUNOASSAY; LABORATORY TEST; MENARCHE; MENSTRUAL CYCLE; MENSTRUATION DISORDER; OLIGOMENORRHEA; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PREGNANCY; PRIORITY JOURNAL; SHORT SURVEY; SKIN SENSITIVITY; STOMACH; THYROID FUNCTION; UPPER LIP; ARTICLE; METABOLISM; THYROID DISEASE; URINE;

17-ALPHA-HYDROXYPROGESTERONE; ADULT; FEMALE; GONADAL STEROID HORMONES; HIRSUTISM; HUMANS; HYDROCORTISONE; HYPERANDROGENISM; MENSTRUATION DISTURBANCES; POLYCYSTIC OVARY SYNDROME; THYROID DISEASES;

EID: 67649101529     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b912     Document Type: Short Survey

References (13)

1. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol 1992;167:1807-1812[ISI][Medline]
2. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA. Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006;91:2-6.[Abstract/Free Full Text] (Pubitemid 43069106)
3. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47[Abstract/ Free Full Text]
4. Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005;83:1717-1723[CrossRef] [Medline] (Pubitemid 40824804)
5. Hahn S, Kuehnel W, Tan S, Kramer K, Schmidt M, Roesler S, et al. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome. Clin Chem Lab Med 2007;45:202-207 [CrossRef][ISI][Medline] (Pubitemid 46294682)
6. Escobar-Morreale HF, Asuncion M, Calvo RM, Sancho J, San Millan JL. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. Eur J Endocrinol 2001;145:619-624[Abstract] (Pubitemid 33069338)
7. Sowers M, Derby C, Jannausch ML, Torrens JI, Pasternak R. Insulin resistance, hemostatic factors, and hormone interactions in pre- and perimenopausal women: SWAN. J Clin Endocrinol Metab 2003;88:4904-4910[Abstract/ Free Full Text] (Pubitemid 37357542)
8. Hopkinson ZEC, Sattar N, Fleming R, Greer IA. Fortnightly review: polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology. BMJ 1998;317:329-332[Free Full Text]
9. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006;91:4237-4245[Abstract/Free Full Text] (Pubitemid 44833391)
10. Azziz R, Nestler J, Dewailly D. Androgen excess disorders in women. Polycystic ovary syndrome and other disorders. Totowa, NJ: Humana Press, 2006.
11. Escobar-Morreale HF, Sanchon R, San Millan JL. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab 2008;93:527-533[Abstract/Free Full Text] (Pubitemid 351240826)
12. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-291[Abstract/Free Full Text] (Pubitemid 32275589)
13. Mengden T, Hubmann P, Muller J, Greminger P, Vetter W. Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome. Clin Investig 1992;70:545-548[ISI] [Medline]